Cas no 28330-02-1 ((Inverted exclamation markA)-Palmitoylcarnitine chloride)
(Inverted exclamation markA)-Palmitoylcarnitine chloride Chemical and Physical Properties
Names and Identifiers
-
- Ammonium,(3-carboxy-2-hydroxypropyl)trimethyl-, chloride, palmitate, D- (8CI)
- Palmiticacid, ester with (3-carboxy-2-hydroxypropyl)trimethylammonium chloride, D-(8CI)
- B6374
- ( inverted exclamation markA)-Palmitoylcarnitine chloride
- (S)-3-Carboxy-N,N,N-trimethyl-2-(palmitoyloxy)propan-1-aminium chloride
- (Inverted exclamation markA)-Palmitoylcarnitine chloride
- 28330-02-1
- D-Palmitoylcarnitine chloride
- [(2S)-3-carboxy-2-hexadecanoyloxypropyl]-trimethylazanium;chloride
- AKOS040755704
- SCHEMBL2785480
- Palmitoyl-D-carnitine (chloride)
- starbld0008669
-
- Inchi: 1S/C23H45NO4.ClH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4;/h21H,5-20H2,1-4H3;1H/t21-;/m0./s1
- InChI Key: GAMKNLFIHBMGQT-BOXHHOBZSA-N
- SMILES: [Cl-].O(C(CCCCCCCCCCCCCCC)=O)[C@@H](CC(=O)O)C[N+](C)(C)C
Computed Properties
- Exact Mass: 435.3115366 g/mol
- Monoisotopic Mass: 435.3115366 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 29
- Rotatable Bond Count: 20
- Complexity: 404
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 63.6
- Molecular Weight: 436.1
(Inverted exclamation markA)-Palmitoylcarnitine chloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci73342-1mg |
Palmitoyl-D-carnitine (chloride) |
28330-02-1 | 98% | 1mg |
¥740.00 | 2022-04-26 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci73342-5mg |
Palmitoyl-D-carnitine (chloride) |
28330-02-1 | 98% | 5mg |
¥2340.00 | 2022-04-26 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci73342-10mg |
Palmitoyl-D-carnitine (chloride) |
28330-02-1 | 98% | 10mg |
¥4340.00 | 2022-04-26 | |
| Larodan | 17-1610-7-25mg |
Hexadecanoyl-D-Carnitine HCl salt |
28330-02-1 | >98% | 25mg |
€317.00 | 2025-03-07 | |
| 1PlusChem | 1P00BSFZ-1mg |
D-Palmitoylcarnitine chloride |
28330-02-1 | ≥98% | 1mg |
$105.00 | 2024-05-07 | |
| 1PlusChem | 1P00BSFZ-5mg |
D-Palmitoylcarnitine chloride |
28330-02-1 | ≥98% | 5mg |
$271.00 | 2024-05-07 | |
| 1PlusChem | 1P00BSFZ-10mg |
D-Palmitoylcarnitine chloride |
28330-02-1 | ≥98% | 10mg |
$482.00 | 2024-05-07 | |
| A2B Chem LLC | AF49279-1mg |
D-Palmitoylcarnitine chloride |
28330-02-1 | ≥98% | 1mg |
$56.00 | 2024-04-20 | |
| A2B Chem LLC | AF49279-5mg |
D-Palmitoylcarnitine chloride |
28330-02-1 | ≥98% | 5mg |
$190.00 | 2024-04-20 | |
| A2B Chem LLC | AF49279-10mg |
D-Palmitoylcarnitine chloride |
28330-02-1 | ≥98% | 10mg |
$350.00 | 2024-04-20 |
(Inverted exclamation markA)-Palmitoylcarnitine chloride Related Literature
-
Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
-
Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
Additional information on (Inverted exclamation markA)-Palmitoylcarnitine chloride
Introduction to (Inverted exclamation markA)-Palmitoylcarnitine Chloride and Its Applications in Modern Research
Compound with the CAS number 28330-02-1, specifically named as (Inverted exclamation markA)-Palmitoylcarnitine chloride, represents a significant compound in the field of biochemical research and pharmaceutical development. This compound, characterized by its unique structural properties, has garnered considerable attention due to its potential applications in various biological processes. The primary focus of this discussion is to delve into the chemical properties, biological significance, and recent advancements in research involving this compound.
The chemical structure of (Inverted exclamation markA)-Palmitoylcarnitine chloride is notable for its composition, which includes a palmitoyl group attached to a carnitine moiety, with the addition of a chloride counterion. This specific arrangement contributes to its solubility and reactivity, making it a valuable tool in biochemical assays. The palmitoyl group, a long-chain fatty acid derivative, plays a crucial role in lipid metabolism, while the carnitine component is essential for the transport of fatty acids into mitochondria for energy production. The chloride ion enhances its stability and compatibility with various biological systems.
Recent studies have highlighted the importance of (Inverted exclamation markA)-Palmitoylcarnitine chloride in understanding metabolic pathways and cellular energy homeostasis. Research has demonstrated that this compound can modulate lipid metabolism by influencing the activity of key enzymes involved in fatty acid oxidation. This modulation is particularly relevant in conditions where energy demands are high, such as during exercise or in response to pathological states like obesity and diabetes. The ability of (Inverted exclamation markA)-Palmitoylcarnitine chloride to interact with mitochondrial enzymes suggests its potential as a therapeutic agent in managing metabolic disorders.
In addition to its role in metabolic processes, (Inverted exclamation markA)-Palmitoylcarnitine chloride has been explored for its potential applications in neuroprotective therapies. Studies indicate that this compound can protect neurons from oxidative stress and inflammation, which are key factors in neurodegenerative diseases such as Alzheimer's and Parkinson's. The mechanism involves the enhancement of mitochondrial function and the reduction of reactive oxygen species (ROS) production. This protective effect has been observed both in vitro and in animal models, paving the way for further clinical investigations.
The compound's unique properties also make it a valuable tool in drug discovery and development. Its ability to interact with specific biological targets allows researchers to design novel molecules with enhanced efficacy and reduced side effects. For instance, derivatives of (Inverted exclamation markA)-Palmitoylcarnitine chloride have been investigated for their potential role in anti-inflammatory treatments. By modulating inflammatory pathways, these derivatives could offer new therapeutic strategies for chronic inflammatory diseases.
Another area where (Inverted exclamation markA)-Palmitoylcarnitine chloride shows promise is in the field of cardiovascular research. Studies have suggested that this compound can improve endothelial function by enhancing nitric oxide production and reducing oxidative stress. These effects are crucial for maintaining vascular health and preventing conditions such as atherosclerosis. The compound's ability to promote vasodilation and inhibit platelet aggregation further underscores its potential as a cardiovascular therapeutic agent.
The synthesis and characterization of (Inverted exclamation markA)-Palmitoylcarnitine chloride have also been refined through recent advancements in chemical methodology. Techniques such as solid-phase synthesis and high-throughput screening have enabled researchers to produce high-purity samples efficiently. These advancements have not only facilitated basic research but also accelerated the development of novel derivatives with tailored properties for specific applications.
Future research directions involving (Inverted exclamation markA)-Palmitoylcarnitine chloride are likely to focus on elucidating its mechanisms of action at a molecular level. Understanding how this compound interacts with cellular components will provide insights into its therapeutic potential and help identify new targets for drug development. Additionally, clinical trials are expected to be conducted to evaluate its efficacy and safety in treating various metabolic and neurological disorders.
In conclusion, (Inverted exclamation markA)-Palmitoylcarnitine chloride is a multifaceted compound with significant implications in biochemical research and pharmaceutical development. Its unique structural properties and biological activities make it a valuable tool for studying metabolic pathways, neuroprotection, anti-inflammatory responses, and cardiovascular health. As research continues to uncover new applications for this compound, it is poised to play an increasingly important role in advancing our understanding of human health and disease.
28330-02-1 ((Inverted exclamation markA)-Palmitoylcarnitine chloride) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)